Unusual Dyslipidemia in Patients with Chronic Kidney Diseases
نویسندگان
چکیده
منابع مشابه
Thyroid dysfunction and dyslipidemia in patients with chronic kidney diseases
Material and methods: A cross-sectional study was conducted among 90 patients with CKD at Saraswathi Institute of Medical Sciences, Hapur (U.P.). Demographic features (age and sex) and medical history of diabetes mellitus, hypertension, and cardiovascular diseases of each patient were noted, and blood samples (5 mL) were analyzed for serum urea, creatinine, glucose, free triiodothyronine (T3), ...
متن کاملNeurologic manifestations in children and adolescents with chronic kidney diseases
Background and Objective: Chronic renal failure (CRF) may have many effects on nervous system and manifest as headache, seizure, dialysis disequilibrium syndrome, cerebral hemorrhage, hypertensive encephalopathy, uremic neuropathy, and some neurologic complications of transplantation. In this present study we investigate neurologic disorders in children with CRF. Methods: In this descriptive...
متن کاملDyslipidemia in patients with chronic and end-stage kidney disease.
In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the ...
متن کاملDyslipidemia in patients with chronic kidney disease: etiology and management
Patients with chronic kidney disease (CKD), including those with end-stage renal disease, treated with dialysis, or renal transplant recipients have an increased risk for cardiovascular disease (CVD) morbidity and mortality. Dyslipidemia, often present in this patient population, is an important risk factor for CVD development. Specific quantitative and qualitative changes are seen at different...
متن کاملDyslipidemia in chronic kidney disease
487 In 1836, Richard Bright commented on the “mil ky serum” of patients with (what today would be called) endstage renal disease (ESRD) – almost certainly the first recognition of hyper lipidemia. The relation between heavy proteinu ria with dyslipidemia had been noted at the be ginning of the 20th century and indeed dyslip idemia in patients with nephrotic proteinuria differs in many res...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
سال: 2017
ISSN: 2249-782X
DOI: 10.7860/jcdr/2017/24172.9220